ResMed Inc - Asset Resilience Ratio
ResMed Inc (RMD) has an Asset Resilience Ratio of 0.06% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check ResMed Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1999–2025)
This chart shows how ResMed Inc's Asset Resilience Ratio has changed over time. See debt-free asset ratio of ResMed Inc to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down ResMed Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see RMD market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $5.47 Million | 0.06% |
| Total Liquid Assets | $5.47 Million | 0.06% |
Asset Resilience Insights
- Limited Liquidity: ResMed Inc maintains only 0.06% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
ResMed Inc Industry Peers by Asset Resilience Ratio
Compare ResMed Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
QITIAN Technology Group Co Ltd
SHE:300061 |
Medical Instruments & Supplies | 0.00% |
|
Visco Vision Inc.
TW:6782 |
Medical Instruments & Supplies | 0.98% |
|
Daxor Corporation
NASDAQ:DXR |
Medical Instruments & Supplies | 65.10% |
|
GETS Global Bhd
KLSE:5079 |
Medical Instruments & Supplies | 0.03% |
|
Osteopore Ltd
AU:OSX |
Medical Instruments & Supplies | 22.60% |
|
Safe Orthopaedics SA
PA:ALSAF |
Medical Instruments & Supplies | 2.20% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
Annual Asset Resilience Ratio for ResMed Inc (1999–2025)
The table below shows the annual Asset Resilience Ratio data for ResMed Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-06-30 | 14.96% | $1.22 Billion | $8.17 Billion | +11.31pp |
| 2024-06-30 | 3.64% | $250.39 Million | $6.87 Billion | +0.08pp |
| 2023-06-30 | 3.56% | $240.31 Million | $6.75 Billion | -1.99pp |
| 2022-06-30 | 5.55% | $282.88 Million | $5.10 Billion | -0.69pp |
| 2021-06-30 | 6.25% | $295.28 Million | $4.73 Billion | -3.85pp |
| 2020-06-30 | 10.10% | $463.16 Million | $4.59 Billion | +6.51pp |
| 2019-06-30 | 3.58% | $147.13 Million | $4.11 Billion | -2.50pp |
| 2018-06-30 | 6.08% | $186.20 Million | $3.06 Billion | -9.65pp |
| 2017-06-30 | 15.73% | $545.43 Million | $3.47 Billion | -- |
| 2016-06-30 | 0.00% | $0.00 | $3.26 Billion | -- |
| 2015-06-30 | 0.00% | $0.00 | $2.18 Billion | -- |
| 2014-06-30 | 0.00% | $0.00 | $2.36 Billion | -- |
| 2013-06-30 | 0.00% | $0.00 | $2.21 Billion | -- |
| 2012-06-30 | 0.00% | $0.00 | $2.14 Billion | -- |
| 2011-06-30 | 0.00% | $0.00 | $2.07 Billion | -- |
| 2007-06-30 | 1.59% | $19.95 Million | $1.25 Billion | -0.60pp |
| 2004-06-30 | 2.19% | $12.02 Million | $549.15 Million | +0.77pp |
| 2003-06-30 | 1.42% | $6.53 Million | $459.60 Million | -3.89pp |
| 2002-06-30 | 5.31% | $19.98 Million | $376.19 Million | -16.42pp |
| 2001-06-30 | 21.73% | $62.62 Million | $288.09 Million | +18.52pp |
| 2000-06-30 | 3.21% | $3.71 Million | $115.59 Million | -3.02pp |
| 1999-06-30 | 6.23% | $5.60 Million | $89.90 Million | -- |
About ResMed Inc
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, h… Read more